Hereditary spherocytosis: From clinical to molecular defects

Haematologica

Volumn 83, Issue 3, 1998, Pages 240-257

  Iolascon, Achille ^a,e   Del Giudice, Emanuele Miraglia ^b   Perrotta, Silverio ^b   Alloisio, Nicole ^c   Morlé, Laurette ^c   Delaunay, Jean ^d  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITÉ LYON 1   (France)

^d BICÊTRE HOSPITAL   (France)

^e Dipartimento di Biomedicina dell'Eta Evolutiva   (Italy)

Author keywords

Ankyrin; Band 3; Cytoskeleton; Hemolytic anemia; Membrane; Spectrin; Spherocytosis

Indexed keywords

CLINICAL EXAMINATION; ERYTHROCYTE DEFORMABILITY; GENE MUTATION; GENETIC ANALYSIS; HEMOLYTIC ANEMIA; HEREDITARY SPHEROCYTOSIS; HUMAN; JAUNDICE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROTEIN DEFECT; REVIEW; SPLENOMEGALY;

ERYTHROCYTES; FAMILY HEALTH; HUMANS; SPHEROCYTOSIS, HEREDITARY;

EID: 0031960386     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (136)

1. Vanlair CF, Masius JB. De la microcythémie. Bull R Acad Med Belg 1871; 5:515-613.
2. Jacob HS, Jandl JH. Increased cell membrane permeability in the pathogenesis of hereditary spherocytosis. J Clin Invest 1964; 43:1704-20.
3. Greenquist AC, Shohet SB. Defective protein phosphorylation in membranes of hereditary spherocytosis erythrocytes. FEBS Letters 1974; 48:133-5.
4. Beutler E, Guinto E, Johnson C. Human red cell protein kinase in normal subjects and patients with hereditary spherocytosis. Blood 1976; 48:887-98.
5. Wolfe LC, Lux SE. Membrane protein phosphorylation of intact normal and hereditary spherocytosis erythrocytes. J Biol Chem 1978; 253:3336-42.
6. Boivin P, Delaunay J, Galand C. Altered erythrocyte membrane protein phosphorylation in an unusual case of hereditary spherocytosis. Scand J Haematol 1979; 23:251-5.
7. Pinder JC, Dhermy D, Baines AJ, Gratzer W. A phenomenological difference between membrane skeleton protein complexes isolated from normal and hereditary spherocytosis erythrocytes. Br J Haematol 1983; 55: 455-63.
8. Morton NE, MacKinney AA, Kosower N, Schilling RF, Gray MP. Genetics of spherocytosis. Am J Hum Genet 1962; 14:170-84.
9. Whitfield CF, Follweiler JB, Lopresti-Morrow L, Miller BA. Deficiency of α-spectrin synthesis in burst-forming units-erychroid in lethal hereditary spherocytosis. Blood 1991; 78:3043-51.
10. Alloisio N, Maillet P, Carré G, et al. Hereditary spherocytosis with band 3 deficiency. Association with a non-sense mutation of the band 3 gene (Allele Lyon), and aggravation by a low-expression allele occurring in trans (Allele Genas). Blood 1996; 88:1062-9.
11. Alloisio N, Texier P, Vallier A, et al. Modulation of clinical expression and band 3 deficiency in hereditary spherocytosis. Blood 1997; 90:414-20.
12. Jarolim P, Rubin HL, Brabec V, Palek J. Comparison of the ankyrin (AC)n microsatellites in genomic DNA and mRNA reveals absence of ankyrin mRNA allele in 20% of patients with hereditary spherocytosis. Blood 1995; 85:3278-82.
13. Miraglia del Giudice E, Hayette S, Bozon M, et al. Ankyrin Napoli: a de novo deletional frameshift mutation in exon 16 of ankyrin gene (ANK1) associated with spherocytosis. Br J Haematol 1996; 93:328-34.
14. Miraglia del Giudice E, Francese M, Nobili B, et al. High frequency of de novo mutations in ankyrin gene (ANK 1) in children with hereditary spherocytosis. J Pediatr 1998; in press.
15. Miraglia del Giudice E, Perrotta S, Iolascon A, et al. Frequent de novo monoallelic expression of one β-spectrin allele (SPTB) in non dominant hereditary spherocytosis with isolated spectrin deficiency. Br J Haematol (submitted).
16. Morlé L, Bozon M, Alloisio N, et al. Ankyrin Bugey: a de novo deletional frameshift variant in exon 6 of the ankyrin gene associated with spherocytosis. Am J Hematol 1997; 54:242-8.
17. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
18. Fairbanks G, Steck TL, Wallach DFH. Electrophoresis of the major polypeptides of the human erythrocyte membrane. Biochemistry 1971; 10:2606-17.
19. Hayashi S, Koomoto R, Yano A, et al. Abnormality in a specific protein of the erythrocyte membrane in hereditary spherocytosis. Biochem Biophys Res Comm 1974; 57:1038-44.
20. Nosawa Y, Noguchi T, Iida H, Fukushima H, Sekiya T, Ito T. Erythrocyte membrane of hereditary spherocytosis: alteration in surface ultrastructure and membrane proteins, as inferred by scanning electron microscopy and SDS-disc gel electrophoresis. Clin Chim Acta 1974; 55:81-5.
21. Agre P, Orringer EP, Bennett V. Deficient red-cell spectrin in severe, recessively inherited spherocytosis. N Engl J Med 1982; 306:1155-61.
22. Agre P, Asimos A, Casella JF, McMillan C. Inheritance pattern and clinical response to splenectomy as a reflection of erythrocyte spectrin deficiency in hereditary spherocytosis. N Engl J Med 1986; 315:1579-83.
23. Nippon). Blood 1992; 79:1846-54.
24. Jarolim P, Palek J, Rubin HL, Prchal JT, Korsgren C, Cohen CM. Band 3 Tuscaloosa: Pro327→Arg327 substitution in the cytoplasmic domain of erythrocyte band 3 protein associated with spherocytic hemolytic anemia and partial deficiency of protein 4.2. Blood 1992; 80:523-9.
25. Becker PS, Tse WT, Lux SE, Forget BG. β-spectrin Kissimmee: a spectrin variant associated with autosomal dominant hereditary spherocytosis and defective binding to protein 4.1. J Clin Invest 1993; 92:612-6.
26. Hassoun H, Vassiliadis JN, Murray J, et al. Molecular basis of spectrin deficiency in β-spectrin Durham. A deletion within β-spectrin adjacent to the ankyrin-binding site precludes spectrin attachment to the membrane in hereditary spherocytosis. J Clin Invest 1995; 96:2623-9.
27. Eber SW, Gonzalez JM, Lux ML, et al. Ankyrin-1 mutations are a major cause of dominant and recessive hereditary spherocytosis. Nat Genet 1996; 13:214-8.
28. Wichterle H, Hanspal M, Palek J, Jarolim P. Combination of two mutant α spectrin alleles underlies a severe spherocytic hemolytic anemia. J Clin Invest 1996; 98: 2300-7.
29. Clark MR, Mohandas N, Shohet SB. Osmotic gradient ektacytometry: comprehensive characterization of the red cell volume and surface maintenance. Blood 1983; 61:899-910.
30. Johnson RM, Ravindranah Y. Osmotic scan ektacytometry in clinical diagnosis. J Pediatr Hematol Oncol 1996; 18:122-9.
31. Pinto L, Iolascon A, Miraglia del Giudice E, Matarese SMR, Nobili B, Perrotta S. The Italian survey on hereditary spherocytosis. Int J Pediatr Hematol Oncol 1995; 2:43-7.
32. Iolascon A, Perrotta S, Tavano R, Miraglia del Giudice E. Hereditary spherocytosis in newborns. In: Bellanti JA, Bracci R, Prindull G and Xanthou M, eds. Neonatal hematology and Immunology. III. Amsterdam: Elsevier Sc. 1997. p. 197-202.
33. Mentzer WC, Iarocci TA, Mohandas N, et al. Modulation of erythrocyte membrane mechanical stability by 2,3-diphosphoglycerate in neonatal poikilocytosis/elliptocytosis syndrome. J Clin Invest 1987; 79:943-7.
34. Wong WJ, Powars DR, Abdalla C, Wu PJK. Phototherapy failure in jaundiced newborns with hereditary spherocytosis. Acta Paediatr Scand 1990; 79:368-9.
35. Lux SE, Palek J. Disorders of red cell membrane. In: Handin RI, Lux SE, Stossel TP, eds. Blood: principles and practice of hematology. Philadelphia: Lippincott Comp.; 1995. p. 1701-818.
36. Hassoun H, Palek J. Hereditary spherocytosis: a review of the clinical and molecular aspects of the disease. Blood Rev 1996; 10:129-47.
37. Eber SW, Armbrust R, Schroter W. Variable clinical severity of hereditary spherocytosis: relation to eryhtocytic spectrin concentration, osmotic fragility and autohemolysis. J Pediatr 1990; 177:409-11.
38. Agre P, Caella JF, Zinkham WH, McMillan C, Bennet V. Partial deficiency of eryhtrocyte spectrin in hereditary spherocytosis. Nature 1985; 314:380-3.
39. Miraglia del Giudice E, Iolascon A, Pinto L, Nobili B, Perrotta S. Erythrocyte membrane protein alterations underlying clinical heterogeneity in hereditary spherocytosis. Br J Haematol 1994; 88:52-5.
40. Miraglia del Giudice E, Perrotta S, Nobili B, Pinto L, Cutillo L, Iolascon A. Coexistence of hereditary spherocytosis (HS) due to band 3 deficiency and β-thalassaemia trait: partial correction of HS phenotype. Br J Haematol 1993; 85:553-7.
41. Alfinito F, Calabrò V, Cappellini MD, et al. G6PD deficiency and red cell membrane defects: additive or synergistic interaction in producing chronic haemolytic anaemia. Br J Haematol 1994; 87:148-52.
42. Yang YM, Donnell C, Wilborn W, et al. Splenic sequestration associated with sickle cell trait and hereditary spherocytosis. Am J Hematol 1992; 40:110-6.
43. Guarnone R, Centenara E, Zappa M, Zanella A, Barosi G. Erythropoietin production and erythropoiesis in compensated and anaemic states of hereditary spherocytosis. Br J Haematol 1996; 92:150-4.
44. Brown K, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993; 260:114-7.
45. Lefrere JJ, Courouce AM, Girot R, Bertrand Y, Soulier JP. Six cases of hereditary spherocytosis revealed by human parvovirus infection. Br J Haematol 1986; 62:653-8.
46. Edwards CQ, Skolnick MH, Dadone MM, Kushner JP. Iron overload in hereditary spherocytosis: association with HLA-linked hemochromatosis. Am J Hematol 1982; 13:101-4.
47. Fargion S, Cappellini MD, Piperno A, Panajotopoulos N, Ronchi G, Fiorelli G. Association of hereditary spherocytosis and idiopathic hemochromatosis: a synergistic effect in determining iron overload. AmJ Clin Pathol 1986; 86:645-7.
48. Marchesi VT, Tillack TW, Jackson RL, Segrest JP, Scott RE. Chemical characterization and surface orientation of the major glycoprotein of the human erythrocyte membrane. Proc Natl Acad Sci USA 1972; 69:1445-51.
49. Tanner MJA. Molecular and cellular biology of the erythrocyte anion exchanger EA1. Semin Hematol 1993; 30:34-57.
50. Kay MMB, Folwers N, Goodman J. Alteration in membrane protein band 3 associated with accelerated erythrocyte ageing. Proc Natl Acad Sci USA 1989; 86: 5834-8.
51. Gallagher PG, Forget GB. Spectrin genes in health and in disease. Semin Hematol 1993; 30:4-21.
52. Liu SC, Derick LH, Palek J. Visualization of the hexagonal lattice in the erythrocyte membrane skeleton. J Cell Biol 1987; 104:527-36.
53. th repetitive unit of erythroid and nonerythroid spectrin. J Cell Biol 1991; 115:267-77.
54. Southgate CD, Chishti AH, Mitchell B, Scott J, Palek J. Targeted disruption of the murine erythroid band 3 gene results in spherocytosis and severe haemolytic anemia despite anormal membrane skeleton. Nat Genet 1996; 14:227-30.
55. Delaunay J. Genetic disorders in the red cell membrane. Crit Rev Oncol Hematol 1995; 19:79-110.
56. Leto TL, Fortugno-Erikson D, Barton DE, et al. Comparison of nonerythroid spectrin genes reveals strict homology among diverse species. Mol Cell Biol 1988; 8:1-9.
57. Watkins PC, Eddy RL, Forget BG, et al. Assignment of the gene for non-erythroid (β-spectrin (SPTBN1) to human chromosome 2p21 [abstract]. Cytogenet Cell Genet 1989; 51:1103.
58. Tse WT, Menninger JC, Yang-Feng TL, et al. Isolation and chromosomal localization of a novel nonerythroid ankyrin gene. Genomics 1991; 10:858-66.
59. Kaphamer D, Miller DE, Lambert S, Bennett V, Glover T, Burmeister M. Chromosomal localization of the ankyrin G gene (ANK3/Ank3) to human 10q21 and mouse 10. Genomics 1995; 27:189-91.
60. Palumbo AP, Isobe M, Huebner K, et al. Chromosomal localization of a human band 3-like gene to region 7q35→q36. Am J Hum Genet 1986; 39:307-16.
61. Su YR, Klanke CA, Houseal TW, et al. Molecular cloning and physical and genetic mapping of the human anion exchanger isoform 3 (SLC2C) gene to chromosome 2q36. Genomics 1994; 22:605-9.
62. Beeton L, Prchal JT, Coetzer TL. A Taq1 polymorphism in the human erythroid β spectrin gene. Hum Genet 1995; 95:365-6.
63. Glele-Kakai C, Garbarz M, Lecomte MC, et al. Epidemiological studies of spectrin mutations related to hereditary elliptocytosis and spectrin polymorphisms in Benin. Br J Haematol 1996; 95:57-66.
64. Gallagher PG, Romana M, Wong C, Forget BG. Genetic basis of the polymorphisms of the α1 domain of spectrin. Am J Hematol 1997; 56:107-11.
65. Tse WT, Gallagher PG, Jenkins PB, et al. An amino acid substitution in α-spectrin commonly inherited with nondominant hereditary spherocytosis. Am J Hematol 1997; 54:233-41.
66. Sahr KE, Laurila P, Kotula L, et al. The complete cDNA and polypeptide sequences of human erythroid α-spectrin. J Biol Chem 1990; 265:4434-43.
67. Kotula L, Laury-Kleintrop LD, Showe L, et al. The exon-intron organization of the human erythrocyte a-spectrin gene. Genomics 1991; 9:131-40.
68. Winkelmann JC, Chang JG, Tse WT, Scarpa AL, Marchesi VT, Forget BG. Full-length sequence of the cDNA for human erythroid β-spectrin. J Biol Chem 1990a; 265:11827-32.
69. Amin KM, Scarpa AL, Winkelmann JC, Curtis PJ, Forget BG. The exon-intron organization of the human erythroid β spectrin gene. Genomics 1993; 18:118-25.
70. Winkelmann JC, Costa FF, Linzie BL, Forget BG. β spectrin in human skeletal muscle. Tissue-specific differential processing of 3′ β spectrin pre-mRNA generates a β spectrin isoform with a unique carboxyl terminus. J Biol Chem 1990; 265:20449-54.
71. Hassoun H, Vassiliadis JN, Murray J, et al. Characterization of the underlying molecular defect in hereditary spherocytosts associated with spectrin deficiency. Blood 1997; 90:398-406.
72. Lux SE, John KM, Bennett V. Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins. Nature 1990; 344:36-42.
73. Gallagher PG, Tse WT, Scarpa AL, Lux SE, Forget BG. Structure and organization of the human ankyrin-1 gene. Basis for complexity of the pre-mRNA processing. J Biol Chem 1997; 272:19220-8.
74. Blank V, Kourilsky P, Israel A. NF-kB and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. TIBS 1992; 17:135-40.
75. Peters LL, Birkenmeier CS, Bronson RT, et al. Purkinje cell degeneration associated with erythroid ankyrin deficiency in nb/nb mice. J Cell Biol 1991; 114:1233-41.
76. Tanner MJA, Martin G, High S. The complete amino acid sequence of the human erythrocyte membrane anion-transport protein deduced from the cDNA sequence. Biochem J 1988; 256:703-12.
77. Lux SE, John KM, Kopito RR, Lodish HF. Cloning and characterization of band 3, the human erythrocyte anion-exchange protein (AE1). Proc Natl Acad Sci USA 1989; 86:9089-93.
78. Sahr KE, Taylor WT, Daniels BP, Lubin HL, Jarolim P. The structure and organization of the human erythroid anion exchanger (AE1) gene. Genomics 1994; 24:491-501.
79. Schofield AE, Martin PG, Spillett D, Tanner MJA. The structure of the human red blood cell anion exchanger (EPB3, AE1, Band 3) gene. Blood 1994; 84:2000-12.
80. Korsgren C, Cohen CM. Organization of the gene for human erythrocyte membrane protein 4.2: structural similarities with the gene for the α subunit of factor XIII. Proc Natl Acad Sci USA 1991; 88:4840-4.
81. Korsgren C, Cohen CM. cDNA sequence, gene sequence, and properties of murine pallidin (band 4.2), the protein implicated in the murine pallid mutation. Genomics 1994; 21:478-85.
82. Risinger MA, Dotimas EM, Cohen CM. Human erythrocyte protein 4.2, a high copy number membrane protein, is N-myristylated. J Biol Chem 1992; 267:5680-5.
83. Das AK, Dasgupta B, Bhattacharya, Basu J. Purification and biochemical characterization of a protein-palmitoyl acykransferase from human erythrocytes. J Biol Chem 1997; 272:11021-5.
84. Sawides P, Shalev O, John KM, Lux SE. Combined spectrin and ankyrin deficiency is common in autosomal dominant hereditary spherocytosis. Blood 1993; 82: 2953-60.
85. Palek J, Jarolim P. Clinical expression and laboratory detection of red cell membrane protein mutations. Semin Hematol 1993; 30:249-83.
86. Saad STO, Costa FF, Vicentin DL, Salles TSI, Pranke PHL. Red cell membrane protein abnormalities in hereditary spherocytosis in Brazil. Br J Haematol 1994; 88:295-9.
87. Lanciotti M, Perutelli P, Valetto A, Di Martino D, Mori PG. Ankyrin deficiency is the most common defect in dominant and non dominant hereditary spherocytosis. Haematologica 1997; 82:460-2.
88. Peters LL, Lux SE. Ankyrins: Structure and function in normal cells and hereditary spherocytes. Semin Hematol 1993; 2:85-118.
89. Miraglia del Giudice E, Francese M, Polito R, Nobili B, Iolascon A, Perrotta S. Apparently normal ankyrin content in unsplenectomized hereditary spherocytosis patients with the inactivation of one ankyrin (ANK1) allele. Haematologica 1997; 82:332-3.
90. Bennett V. Ankyrins: adaptors between diverse plasma membrane proteins and the cytoplasm. J Biol Chem 1992; 267:8703-6.
91. Michaely P, Bennett V. The membrane binding domain of ankyrin contains four independently folded subdomains, each comprised of six ankyrin repeats. J Biol Chem 1993; 268:22703-9.
92. Michaely P, Bennett V. The ankyrin repeats of erythrocyte ankyrin form two distinct but cooperative binding sites for the erythrocyte anion exchanger. J Biol Chem 1995; 270:22050-7.
93. Pekrun A, Eber SW, Kuhlmey A, Schroter W. Combined spectrin and ankyrin deficiency in hereditary spherocytosis. Ann Hematol 1993; 67:89-93.
94. Hanspal M, Yoon SH, Yu H, et al. Molecular basis of spectrin and ankyrin deficiencies in severe hereditary spherocytosis: evidence implicating a primary defect of ankyrin. Blood 1991; 77:165-73.
95. Randon J, Miraglia del Giudice E, Bozon M, et al. Frequent de novo mutations of the ANK1 gene mimic a recessive mode of transmission in hereditary spherocytosis: three new ANK1 variants: ankyrins Bari, Napoli II and Anzio. Br J Haematol 1997; 96:500-6.
96. Inoue T, Kanzaki A, Yawata A, et al. Even partial deficiency of protein 4.2 is critical for integrity of skeletal network in situ and intramembrane particles in a homozygous band 3 Fukuoka (G130R) with its impaired binding to protein 4.2. Blood 1996:88 (Suppl 1; Part 2), 5b.
97. Jarolim P, Murray JL, Rubin HL, et al. Characterization of 13 novel band 3 gene defects in hereditary spherocytosis with band 3 deficiency. Blood 1996; 88:4366-74.
98. Jenkins PB, Abou-Alfa GK, Dhermy D, et al. A nonsense mutation in the erythrocyte band 3 gene associated with decreased mRNA accumulation in a kindred with dominant hereditary spherocytosis. J Clin Invest 1996; 97:373-80.
99. Lima PRM, Gontijo JAR, Lopes de Faria JB, Costa FF, Saad STO. Band 3 Campinas: a novel splicing mutation in the band 3 gene (AE1) associated with hereditary spherocytosis. Hyperactivity of the Na+/Li+ counter-transport and an abnormal renal bicarbonate handling [abstract]. Blood 1996; 88 (Suppl 1):462a.
100. Bianchi P, Zanella A, Alloisio N, et al. A variant of the EPB3 gene of the anti-Lepore type in hereditary spherocytosis. BrJ Haematol 1997; 98:283-8.
101. Dhermy D, Galand C, Bournier O, et al. Heterogenous band 3 deficiency in hereditary spherocytosis related to band 3 deficiency. Br J Haematol 1997; 98:32-40.
102. Miraglia del Giudice E, Vallier A, Maillet P, et al. Novel band 3 variants (bands 3 Foggia, Napoli I and Napoli II) associated with hereditary spherocytosis and band 3 deficiency. Status of the D38A locus polymorphism of the EPB3 locus. Br J Haematol 1997; 96:70-6.
103. Kanzaki A, Hayette S, Morlé L, et al. Association of hereditary spherocytosis with partial deficiency of band 3 and absence of protein 4.2. Compound heterozygosity for band 3 Okinawa and band 3 Fukuoka. Br J Haematol 1998; in press.
104. Delaunay J, Alloisio N, Morlé L, et al. Molecular genetics of hereditary elliptocytosis and hereditary spherocytosis. Ann Gen 1996; 39:209-21.
105. Jarolim P, Rubin HL, Liu SC, et al. Duplication of 10 nucleotides in the erythroid band 3 (AE1) gene in a kindred with hereditary spherocytosis and band 3 protein deficiency (band 3 PRAGUE). J Clin Invest 1994; 93: 121-30.
106. Jarolim P, Rubin HL, Brabec V, et al. Mutations of conserved arginines in the membrane domain of erythroid band 3 lead to a decrease in membrane-associated band 3 and to the phenotype of hereditary spherocytosis. Blood 1995; 85:634-40.
107. Inaba M, Yawata A, Koshino I, et al. Defective anion transport and marked spherocytosis with membrane instability caused by hereditary total deficiency of red cell band 3 in cattle due to a nonsense mutation. J Clin Invest 1996; 97:1804-17.
108. Peters LL, Shivdasani RA, Liu SC, et al. Anion exchanger 1 (Band 3) is required to prevent erythrocyte surface loss but not to form the membrane skeleton. Cell 1996; 86:917-27.
109. Rybicki AC, Qiu JJH, Musto S, Rosen NL, Nagel RL, Schwartz RS. Human erythrocyte protein 4.2 deficiency associated with hemolytic anemia and a homozygous 40 glutamic acid→lysine substitution in the cytoplasmic domain of band 3 (band 3 Montefiore). Blood 1993; 81:2155-65.
110. Tanner MJA, Bruce LJ, Cope D, et al. Altered red cell properties in South East Asian ovalocytic (SAO) and a family with familial distal renal tubular acidosis (DRTA). EHA Working Group on Red Cell Membrane, Second Meeting, May 28-29, 1996, Le Kremlin-Bicêtre, France.
111. Cohen CM, Dotimas E, Korsgren C. Human erythrocyte membrane protein band 4.2 (Pallidin). Semin Hematol 1993; 30:119-37.
112. Yawata Y. Red cell membrane protein band 4.2: phenotypic, genetic and electron microscopic aspects. Biochim Biophys Acta 1994; 1204:131-48.
113. Kanzaki A, Yawata Y, Yawata A, et al. Band 4.2 Komatsu: 523 GAT→TAT (175 Asp→Tyr) in exon 4 of the band 4.2 gene associated with total deficiency of band 4.2, hemolytic anemia with ovalostomatocytosis and marked disruption of the cytoskeletal network. Int J Hematol 1995; 61:165-78.
114. NOTAME). Hum Mol Gen 1995; 4:1187-91.
115. FUKUOKA). Br J Haematol 1994; 88:527-33.
116. Kanzaki A, Yasunaga M, Okamoto N, et al. Band 4.2 Shiga: 317 CGC→TGC in compound heterozygotes with 142 GCT→ACT results in band 4.2 deficiency and microspherocytosis. Br J Haematol 1995; 91:333-40.
117. Tozeur) associated with hereditary haemolytic anaemia. Br J Haematol 1995; 89:762-70.
118. Hayette S, Dhermy D, dos Santos ME, et al. A deletion frameshift mutation in protein 4.2 gene (allele 4.2 Lisboa) associated with hereditary hemolytic anemia. Blood 1995; 85:250-6.
119. Hanspal M, Palek J. Synthesis and assembly of membrane skeletal proteins in mammalian red cell precursors. J Cell Biol 1987; 105:1417-24.
120. Marchesi SL, Agre P, Speicher DW. Abnormal spectrin all domain in recessive spherocytosis. J Cell Biochem 1989; 13B:213a.
121. Marchesi SL, Agre P, Speicher DW, Tse WT, BG Forget. Mutant spectrin all domain in recessively inherited spherocytosis. Blood 1989; 74 (suppl. 1):182a.
122. Jarolim P, Wichterle H, Palek J, Gallagher PG, Forget BG. The low expression α-spectrin Lepra is frequently associated with autosomal recessive/non-dominant hereditary spherocytosis. Blood 1996; 88 (suppl. 1):4a.
123. Hassoun H, Vassiliadis JN, Murray J, et al. Hereditary spherocytosis with spectrin deficiency due to an unstable truncated β spectrin. Blood 1996; 87:2538-45.
124. Hassoun H, Vassiliadis JN, Murray J, et al. Characterization of the underlying molecular defect in hereditary spherocytosis associated with spectrin deficiency. Blood 1997; 90:398-406.
125. Bianco I, Cappabianca MP, Foglietta E, et al. Silent thalassemias: genotypes and phenotypes. Haematologica 1997; 82:269-80.
126. Bianco I, Lerone M, Foglietta E, et al. Phenotypes of individuals with a β thal classical allele associated either with a β thal silent allele or with α globin gene triplication. Haematologica 1997; 82:513-25
127. Lortan JE. Management of asplenic patients. Br J Haematol 1993; 84:566-9.
128. Patton ML, Moss BE, Haith LR, et al. Concomitant laparoscopic cholecystectomy and splenectomy for surgical management of hereditary spherocytosis. Am J Surg 1997; 63:536-9.
129. Tchernia G, Bader-Meunier B, Berterottiere P, Eber S, Dommergues JP, Gauthier F. Effectiveness of partial splenectomy in hereditary spherocytosis. Curr Opin Hematol 1997; 4:136-41.
130. O'Neal BJ, McDonald JC. The risk of sepsis in asplenic adult. Ann Surg 1981; 194:775-8.
131. Bridgen ML. Overwhelming infections after splenectomy infection: still a problem. West J Med 1992; 157:440-3.
132. Bridgen ML. Post-splenectomy sepsis syndrome. Post-grad Med 1985; 77:215-26.
133. Noms RP, Vergis EN, Yu VL. Overwhelming post-splenectomy infections: a critical review of etiologic pathogens and management. Infect Med 1996; 13:779-83.
134. Read RC, Finch RG. Prophylaxis after splenectomy. J Antimicrob Chemother 1994; 33:4-6.
135. McMullin M, Johnston G. Long-term management of patients after splenectomy. Br Med J 1993; 307:1372-3.
136. Buchanan GR. Chemoprophylaxis in asplenic adolescents and young adults. Pediatr Infect Dis 1993; 12:892-3.